What is the Future of Catalytic Inhibitors in Cancer Treatment?
The future of catalytic inhibitors in cancer treatment looks promising with ongoing research aiming to address current challenges. Advances in precision medicine, combination therapies, and personalized treatment plans are expected to improve the efficacy and safety of these inhibitors. Additionally, biomarker-driven approaches can help identify patients who are most likely to benefit from specific catalytic inhibitors, thereby enhancing treatment outcomes.
